Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics A coalition of strategic industry leaders – including Cardinal Health, Novartis Pharma AG, and Kite, a Gilead Company (Gilead Sciences, Inc.) – joins the company’s existing investor syndicate to...